Order Article Reprints

Furlan A, Rossi MC, Gherlinzoni F, Scotton P. Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution. Hematology Reports. 2022; 14(2):135-142. https://doi.org/10.3390/hematolrep14020020

Furlan, Anna, Maria Cristina Rossi, Filippo Gherlinzoni, and Piergiorgio Scotton. 2022. "Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution" Hematology Reports 14, no. 2: 135-142. https://doi.org/10.3390/hematolrep14020020

Furlan, A., Rossi, M. C., Gherlinzoni, F., & Scotton, P. (2022). Prompt Hematological Recovery in Response to a Combination of Pegylated Interferon α-2a and Rituximab in a Profoundly Immuno-Suppressed Hairy Cell Leukemia Patient with a Mycobacterial Infection at Onset: Benefits and Drawbacks of Rapid Immune Reconstitution. Hematology Reports, 14(2), 135-142. https://doi.org/10.3390/hematolrep14020020